Eden Research PLC (EDEN)

Industry Agricultural Inputs
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

4.00p

Buy

4.20p

arrow-up0.20p (+5.13%)

Eden Research PLC is a UK based company engaged in the development and marketing of intellectual property, particularly in terpenes and other health related projects. It operates through Biocides and Human health, Animal health and Agrochemical segments.
Prices updated at 16 May 2025, 17:20 BST
| Prices minimum 15 mins delay
|
Prices in GBX
FTSE All-Share
arrow-up0.59%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Basic Materials
Industry
Agricultural Inputs
Chairman
Mr. Lykele van der Broek
CEO
Mr. Sean Michael Smith
Most recent earnings
31 Dec 2023
Fiscal year end
31 Dec 2023
Employees
19
Head office
67C Innovation Drive
Abingdon
United Kingdom
OX14 4RQ
mobile
+44 1285359555
letter
info@edenresearch.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Lykele van der Broek
Non-Executive Director, Chairman
---0.05m-
Mr. Robin James Scott Cridland
Non-Executive Director
---0.04m-
Mr. Derek Ian McAllan
Non-Executive Director
-----
Mr. Alexander John Abrey
Executive Director, Chief Financial Officer and Company Secretary
-----
Mr. Sean Michael Smith
Executive Director, Chief Executive Officer
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Octopus Investments Limited40,363,0501.6835524297116-30 Apr 20257.57
Baronsmead Second Venture Trust30,512,1950.5816616006932110.3525830 Apr 20255.72
Hargreave Hale Limited28,615,3850.8367225911-30 Apr 20255.37
Octopus AIM VCT ORD24,317,0730.8467124317073-30 Apr 20254.56
Unicorn Asset Management Ltd23,076,9230.34298--30 Apr 20254.33

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
01 Apr 2025PurchaseMr. Alexander John Abrey2.367,9892,821,1880.53-
01 Apr 2025PurchaseMr. Sean Michael Smith2.349,9912,669,1440.50-
05 Mar 2025PurchaseMr. Lykele van der Broek3.3015,8402,357,8080.44-
04 Mar 2025PurchaseMr. Alexander John Abrey2.974,9882,482,6790.47-
04 Mar 2025PurchaseMr. Sean Michael Smith3.0410,0032,242,1580.42-
04 Mar 2025PurchaseMr. Derek Ian McAllan3.107,489843,6270.16-
06 Feb 2025PurchaseMr. Lykele van der Broek3.909,9841,877,8080.35-
28 Jan 2025PurchaseMr. Alexander John Abrey3.7020,0002,314,7320.43-
28 Jan 2025PurchaseMr. Sean Michael Smith3.7020,0001,913,1170.36-
28 Jan 2025PurchaseMr. Derek Ian McAllan3.589,989602,0390.11-
10 Jul 2024PurchaseMr. Derek Ian McAllan4.6415,000323,0170.06-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.